Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association.

Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M.

Diabetes Care. 2016 Dec;39(12):2126-2140. Review. No abstract available. Erratum in: Diabetes Care. 2016 Dec 7;:. Diabetes Care. 2017 Mar 24;:. Diabetes Care. 2017 May;40(5):726.

PMID:
27879358
2.

Prevalence and predictors of depression and anxiety in patients of diabetes mellitus in a tertiary care center.

Rajput R, Gehlawat P, Gehlan D, Gupta R, Rajput M.

Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):746-751.

3.

The Influence of Health Literacy and Depression on Diabetes Self-Management: A Cross-Sectional Study.

Maneze D, Everett B, Astorga C, Yogendran D, Salamonson Y.

J Diabetes Res. 2016;2016:3458969. doi: 10.1155/2016/3458969. Epub 2016 Aug 10.

4.

The association between Diabetes mellitus and Depression.

Bădescu SV, Tătaru C, Kobylinska L, Georgescu EL, Zahiu DM, Zăgrean AM, Zăgrean L.

J Med Life. 2016 Apr-Jun;9(2):120-5. Review.

5.

Association between depressive symptoms, use of antidepressant medication and the metabolic syndrome: the Maine-Syracuse Study.

Crichton GE, Elias MF, Robbins MA.

BMC Public Health. 2016 Jun 10;16:502. doi: 10.1186/s12889-016-3170-2.

6.

Effect of serotonin modulating pharmacotherapies on body mass index and dysglycaemia among children and adolescents: a systematic review and network meta-analysis protocol.

Al Khalifah RA, De Long NE, Florez ID, Mbuagbaw L, Morrison KM.

BMJ Open. 2016 Mar 16;6(3):e009998. doi: 10.1136/bmjopen-2015-009998.

7.
8.

Commentary: Antidepressants and diabetes risk: why are there discrepant findings from cohort studies based on patient records and those based on serial phenotyping?

Kivimäki M, Batty GD.

Int J Epidemiol. 2015 Dec;44(6):1940-2. doi: 10.1093/ije/dyv186. Epub 2015 Sep 13. No abstract available.

9.

Depressive symptoms, psychiatric medication use, and risk of type 2 diabetes: results from the Health and Retirement Study.

Ratliff S, Mezuk B.

Gen Hosp Psychiatry. 2015 Sep-Oct;37(5):420-6. doi: 10.1016/j.genhosppsych.2015.05.008. Epub 2015 May 29.

10.

Effect of Psychotropic Drugs on Development of Diabetes Mellitus in Patients With Alzheimer's Disease.

Chang KJ, Hong CH, Lee Y, Lee KS, Roh HW, Back JH, Jung YK, Lim KY, Noh JS, Kim HC, Choi SH, Kim SY, Na DL, Seo SW, Lee S, Son SJ.

Medicine (Baltimore). 2015 Jun;94(23):e919. doi: 10.1097/MD.0000000000000919.

11.

Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.

Hostalek U, Gwilt M, Hildemann S.

Drugs. 2015 Jul;75(10):1071-94. doi: 10.1007/s40265-015-0416-8. Review.

12.

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Correll CU, Detraux J, De Lepeleire J, De Hert M.

World Psychiatry. 2015 Jun;14(2):119-36. doi: 10.1002/wps.20204.

13.

Association between major depression and type 2 diabetes in midlife: findings from the Screening Across the Lifespan Twin Study.

Mezuk B, Heh V, Prom-Wormley E, Kendler KS, Pedersen NL.

Psychosom Med. 2015 Jun;77(5):559-66. doi: 10.1097/PSY.0000000000000182.

14.

The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.

Habib M, Shaker S, El-Gayar N, Aboul-Fotouh S.

PLoS One. 2015 Mar 31;10(3):e0120559. doi: 10.1371/journal.pone.0120559. eCollection 2015.

15.

Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.

Marrero DG, Ma Y, de Groot M, Horton ES, Price DW, Barrett-Connor E, Carnethon MR, Knowler WC; Diabetes Prevention Program Research Group..

Psychosom Med. 2015 Apr;77(3):303-10. doi: 10.1097/PSY.0000000000000156.

16.

Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS).

Diabetes Prevention Program (DPP) Research Group., Hamman RF, Horton E, Barrett-Connor E, Bray GA, Christophi CA, Crandall J, Florez JC, Fowler S, Goldberg R, Kahn SE, Knowler WC, Lachin JM, Murphy MB, Venditti E.

Diabetes. 2015 Mar;64(3):989-98. doi: 10.2337/db14-0333. Epub 2014 Oct 2.

17.

Depression, stress, and weight loss in individuals with metabolic syndrome in SHINE, a DPP translation study.

Trief PM, Cibula D, Delahanty LM, Weinstock RS.

Obesity (Silver Spring). 2014 Dec;22(12):2532-8. doi: 10.1002/oby.20916. Epub 2014 Sep 24.

18.

NIDDK international conference report on diabetes and depression: current understanding and future directions.

Holt RI, de Groot M, Lucki I, Hunter CM, Sartorius N, Golden SH.

Diabetes Care. 2014 Aug;37(8):2067-77. doi: 10.2337/dc13-2134.

19.

Depression and ambulatory care sensitive hospitalizations among Medicare beneficiaries with chronic physical conditions.

Bhattacharya R, Shen C, Sambamoorthi U.

Gen Hosp Psychiatry. 2014 Sep-Oct;36(5):460-5. doi: 10.1016/j.genhosppsych.2014.05.020. Epub 2014 Jun 4.

20.

Prevalence of depression and use of antidepressant pharmacotherapy among ambulatory patients with diabetes mellitus in the United States.

Neumiller JJ, Sclar DA, Robison LM, Setter SM, Skaer TL.

Curr Ther Res Clin Exp. 2009 Dec;70(6):472-6. doi: 10.1016/j.curtheres.2009.12.001.

Supplemental Content

Support Center